Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) randomized clinical trial

Authors

Daniel J Goldstein, Montefiore Einstein Center for Heart and Vascular Care
Akinobu Itoh, Washington University School of Medicine in St. Louis
et al

Journal

JAMA Cardiology

Publication Date

1-15-2020

Volume

5

Issue

4

First Page

411

Last Page

419

Document Type

Open Access Publication

DOI

10.1001/jamacardio.2019.5323

Rights and Permissions

Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC Jr, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. JAMA Cardiol. 2020 Apr 1;5(4):411-419. doi: 10.1001/jamacardio.2019.5323 This is an open access article distributed under the terms of the CC-BY-NC-ND License. © 2020 Goldstein DJ et al. JAMA Cardiology.

Recommended Citation

Goldstein, Daniel J; Itoh, Akinobu; and et al, "Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) randomized clinical trial." JAMA Cardiology. 5, 4. 411 - 419. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/12036